Therefore, it seems that OX40–OX40L signaling is more involved in the pathogenesis of MS, and humoral immunity (autoantibodies against AQP4) is predominantly involved in NMO pathogenesis. Here, TNFRSF4 is linked to myeloid sarcoma.